Hummell D S, Swift A J, Tomasz A, Winkelstein J A
Infect Immun. 1985 Feb;47(2):384-7. doi: 10.1128/iai.47.2.384-387.1985.
Cell wall teichoic acids of some gram-positive bacteria are potent activators of the alternative pathway of complement. It is unclear, however, whether the other form of teichoic acid, cell membrane lipoteichoic acid (LTA), can also activate the alternative pathway. In the present study, radiolabelled pneumococcal LTA was found to bind spontaneously to sheep erythrocytes in a temperature- and time-dependent fashion. In addition, the presence of pneumococcal LTA on the erythrocyte surface was verified by the fact that they could be agglutinated by a myeloma protein (TEPC-15) specific for choline, a constituent of pneumococcal LTA. Pneumococcal LTA when fixed to the surface of erythrocytes was able to activate the alternative pathway of complement in both guinea pig serum deficient in the fourth component of complement and human serum deficient in the second component of complement, resulting in lysis of the sensitized erythrocytes. The sensitizing principle of the LTA preparation was removed before erythrocyte sensitization by immunoabsorption, using the choline-specific TEPC-15 myeloma protein. These data demonstrate that purified pneumococcal LTA will bind to sheep erythrocytes and endow them with the ability to activate the alternative pathway.
一些革兰氏阳性菌的细胞壁磷壁酸是补体替代途径的有效激活剂。然而,尚不清楚另一种形式的磷壁酸,即细胞膜脂磷壁酸(LTA)是否也能激活替代途径。在本研究中,发现放射性标记的肺炎球菌LTA以温度和时间依赖性方式自发结合到绵羊红细胞上。此外,红细胞表面存在肺炎球菌LTA可通过以下事实得到证实:它们可被针对肺炎球菌LTA成分胆碱的骨髓瘤蛋白(TEPC-15)凝集。当固定在红细胞表面时,肺炎球菌LTA能够在缺乏补体第四成分的豚鼠血清和缺乏补体第二成分的人血清中激活补体替代途径,导致致敏红细胞溶解。在红细胞致敏前,使用胆碱特异性TEPC-15骨髓瘤蛋白通过免疫吸附去除LTA制剂的致敏原理。这些数据表明,纯化的肺炎球菌LTA将结合到绵羊红细胞上,并赋予它们激活替代途径的能力。